Answer
Yes. BCR-ABL inhibitors can reactivate hepatitis B, occasionally causing severe liver failure, so hepatitis B testing is required before treatment.
Sources for this answer
- Nilotinib 150mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.